Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis
Abstract
To clarify the effects of follow-on therapy after denosumab (DMAb) discontinuation.In this retrospective, multicenter study, postmenopausal patients with osteoporosis who were previously treated by oral bisphosphonates (BP) (n = 26) or teriparatide (TPTD) (n = 27) were switched to DMAb (administered 2.6 times), and then discontinued. Patients (73.1 years, T-scores of the lumbar spine [LS] - 2.7 and femoral neck [FN] - 2.2) were switched to...
Paper Details
Title
Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis
Published Date
Jun 8, 2020
Journal
Volume
31
Issue
2
Pages
485 - 492
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History